MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 64 filers reported holding MERUS N V in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,433,235 | +12.8% | 484,870 | +26.0% | 3.56% | +28.3% |
| Q2 2023 | $10,133,627 | +93.9% | 384,870 | +35.5% | 2.77% | +76.8% |
| Q1 2023 | $5,225,563 | +25.2% | 283,998 | +5.2% | 1.57% | +33.2% |
| Q4 2022 | $4,175,245 | -24.7% | 269,893 | -2.5% | 1.18% | -21.2% |
| Q3 2022 | $5,546,000 | -6.8% | 276,893 | +5.3% | 1.49% | -8.0% |
| Q2 2022 | $5,952,000 | -4.2% | 262,891 | +11.9% | 1.62% | +0.2% |
| Q1 2022 | $6,213,000 | -13.6% | 234,989 | +3.9% | 1.62% | -10.5% |
| Q4 2021 | $7,190,000 | +147.7% | 226,089 | +71.3% | 1.81% | +134.8% |
| Q3 2021 | $2,903,000 | -12.7% | 131,949 | -16.4% | 0.77% | +10.6% |
| Q2 2021 | $3,326,000 | +0.9% | 157,841 | 0.0% | 0.70% | -11.0% |
| Q1 2021 | $3,297,000 | – | 157,841 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |